48 results on '"Chopin LK"'
Search Results
2. Multi-species sequence comparison reveals conservation of ghrelin gene-derived splice variants encoding a truncated ghrelin peptide
- Author
-
Seim, I, Jeffery, PL, Thomas, PB, Walpole, CM, Maugham, M, Fung, JNT, Yap, P-Y, O'Keeffe, AJ, Lai, J, Whiteside, EJ, Herington, AC, Chopin, LK, Seim, I, Jeffery, PL, Thomas, PB, Walpole, CM, Maugham, M, Fung, JNT, Yap, P-Y, O'Keeffe, AJ, Lai, J, Whiteside, EJ, Herington, AC, and Chopin, LK
- Abstract
The peptide hormone ghrelin is a potent orexigen produced predominantly in the stomach. It has a number of other biological actions, including roles in appetite stimulation, energy balance, the stimulation of growth hormone release and the regulation of cell proliferation. Recently, several ghrelin gene splice variants have been described. Here, we attempted to identify conserved alternative splicing of the ghrelin gene by cross-species sequence comparisons. We identified a novel human exon 2-deleted variant and provide preliminary evidence that this splice variant and in1-ghrelin encode a C-terminally truncated form of the ghrelin peptide, termed minighrelin. These variants are expressed in humans and mice, demonstrating conservation of alternative splicing spanning 90 million years. Minighrelin appears to have similar actions to full-length ghrelin, as treatment with exogenous minighrelin peptide stimulates appetite and feeding in mice. Forced expression of the exon 2-deleted preproghrelin variant mirrors the effect of the canonical preproghrelin, stimulating cell proliferation and migration in the PC3 prostate cancer cell line. This is the first study to characterise an exon 2-deleted preproghrelin variant and to demonstrate sequence conservation of ghrelin gene-derived splice variants that encode a truncated ghrelin peptide. This adds further impetus for studies into the alternative splicing of the ghrelin gene and the function of novel ghrelin peptides in vertebrates.
- Published
- 2016
3. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines
- Author
-
Jeffery, PL, primary, Herington, AC, additional, and Chopin, LK, additional
- Published
- 2002
- Full Text
- View/download PDF
4. Unpacking and validating the "cell-cell communication" core concept of physiology by an Australian team.
- Author
-
Chopin LK, Choate J, Rathner JA, Towstoless M, Hayes A, Hryciw DH, Lexis L, and Tangalakis K
- Subjects
- Humans, Australia, Learning, Cell Communication, Curriculum, Physiology education
- Abstract
An Australia-wide consensus was reached on seven core concepts of physiology, one of which was cell-cell communication. Three physiology educators from a "core concepts" Delphi task force "unpacked" this core concept into seven different themes and 60 subthemes. Cell-cell communication, previously unpacked and validated, was modified for an Australian audience to include emerging knowledge and adapted to increase student accessibility. The unpacked hierarchical framework for this core concept was rated by 24 physiology educators from separate Australian universities, using a five-point scale for level of importance for student understanding (ranging from 1 = Essential to 5 = Not Important) and level of difficulty (ranging from 1 = Very Difficult to 5 = Not Difficult). Data were analyzed with the Kruskal-Wallis test with Dunn's multiple comparison test. The seven themes were rated within a narrow range of importance (1.13-2.4), with ratings of Essential or Important, and statistically significant differences between the themes ( P < 0.0001, n = 7). The variance for the difficulty rating was higher than for importance, ranging from 2.15 (Difficult) to 3.45 (between Moderately Difficult and Slightly Difficult). Qualitatively, it was suggested that some subthemes were similar and that these could be grouped. However, all themes and subthemes were ranked as Important, validating this framework. Once finalized and adopted across Australian universities, the unpacked core concept for cell-cell communication will enable the generation of tools and resources for physiology educators and improvements in consistency across curricula. NEW & NOTEWORTHY Seven core concepts, including cell-cell communication, were identified by an Australian Delphi task force of physiology educators. The previously "unpacked" concept was adapted for Australian educators and students to develop a framework with seven themes and 60 subthemes. The framework was successfully validated by the original Delphi panel of educators and will provide a valuable resource for teaching and learning in Australian universities.
- Published
- 2023
- Full Text
- View/download PDF
5. A chromosome-level genome of Antechinus flavipes provides a reference for an Australian marsupial genus with male death after mating.
- Author
-
Tian R, Han K, Geng Y, Yang C, Shi C, Thomas PB, Pearce C, Moffatt K, Ma S, Xu S, Yang G, Zhou X, Gladyshev VN, Liu X, Fisher DO, Chopin LK, Leiner NO, Baker AM, Fan G, and Seim I
- Subjects
- Animals, Australia, Chromosomes, Male, Reproduction, Marsupialia genetics
- Abstract
The 15 species of small carnivorous marsupials that comprise the genus Antechinus exhibit semelparity, a rare life-history strategy in mammals where synchronized death occurs after one breeding season. Antechinus males, but not females, age rapidly (demonstrate organismal senescence) during the breeding season and show promise as new animal models of ageing. Some antechinus species are also threatened or endangered. Here, we report a chromosome-level genome of a male yellow-footed antechinus Antechinus flavipes. The genome assembly has a total length of 3.2 Gb with a contig N50 of 51.8 Mb and a scaffold N50 of 636.7 Mb. We anchored and oriented 99.7% of the assembly on seven pseudochromosomes and found that repetitive DNA sequences occupy 51.8% of the genome. Draft genome assemblies of three related species in the subfamily Phascogalinae, two additional antechinus species (Antechinus argentus and A. arktos) and the iteroparous sister species Murexia melanurus, were also generated. Preliminary demographic analysis supports the hypothesis that climate change during the Pleistocene isolated species in Phascogalinae and shaped their population size. A transcriptomic profile across the A. flavipes breeding season allowed us to identify genes associated with aspects of the male die-off. The chromosome-level A. flavipes genome provides a steppingstone to understanding an enigmatic life-history strategy and a resource to assist the conservation of antechinuses., (© 2021 The Authors. Molecular Ecology Resources published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
6. A Chromosome-Level Genome of the Agile Gracile Mouse Opossum (Gracilinanus agilis).
- Author
-
Tian R, Han K, Geng Y, Yang C, Guo H, Shi C, Xu S, Yang G, Zhou X, Gladyshev VN, Liu X, Chopin LK, Fisher DO, Baker AM, Leiner NO, Fan G, and Seim I
- Subjects
- Animals, Female, Genomics, Male, Molecular Sequence Annotation, Chromosomes genetics, Genome, Opossums genetics
- Abstract
There are more than 100 species of American didelphid marsupials (opossums and mouse opossums). Limited genomic resources for didelphids exists, with only two publicly available genome assemblies compared with dozens in the case of their Australasian counterparts. This discrepancy impedes evolutionary and ecological research. To address this gap, we assembled a high-quality chromosome-level genome of the agile gracile mouse opossum (Gracilinanus agilis) using a combination of stLFR sequencing, polishing with mate-pair data, and anchoring onto pseudochromosomes using Hi-C. This species employs a rare life-history strategy, semelparity, and all G. agilis males and most females die at the end of their first breeding season after succumbing to stress and exhaustion. The 3.7-Gb chromosome-level assembly, with 92.6% anchored onto pseudochromosomes, has a scaffold N50 of 683.5 Mb and a contig N50 of 56.9 kb. The genome assembly shows high completeness, with a mammalian BUSCO score of 88.1%. Around 49.7% of the genome contains repetitive elements. Gene annotation yielded 24,425 genes, of which 83.9% were functionally annotated. The G. agilis genome is an important resource for future studies of marsupial biology, evolution, and conservation., (© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.)
- Published
- 2021
- Full Text
- View/download PDF
7. The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.
- Author
-
Thomas PB, Jeffery P, Gahete MD, Whiteside E, Walpole C, Maugham M, Jovanovic L, Gunter J, Williams E, Nelson C, Herington A, Luque RM, Veedu R, Chopin LK, and Seim I
- Abstract
It is now appreciated that long non-coding RNAs (lncRNAs) are important players in orchestrating cancer progression. In this study we characterized GHSROS , a human lncRNA gene on the opposite DNA strand (antisense) to the ghrelin receptor gene, in prostate cancer. The lncRNA was upregulated by prostate tumors from different clinical datasets. Transcriptome data revealed that GHSROS alters the expression of cancer-associated genes. Functional analyses in vitro showed that GHSROS mediates tumor growth, migration and survival, and resistance to the cytotoxic drug docetaxel. Increased cellular proliferation of GHSROS -overexpressing PC3, DU145, and LNCaP prostate cancer cell lines in vitro was recapitulated in a subcutaneous xenograft model. Conversely, in vitro antisense oligonucleotide inhibition of the lncRNA reciprocally regulated cell growth and migration, and gene expression. Notably, GHSROS modulates the expression of PPP2R2C , the loss of which may drive androgen receptor pathway-independent prostate tumor progression in a subset of prostate cancers. Collectively, our findings suggest that GHSROS can reprogram prostate cancer cells toward a more aggressive phenotype and that this lncRNA may represent a potential therapeutic target., Competing Interests: The authors declare there are no competing interests., (©2021 Thomas et al.)
- Published
- 2021
- Full Text
- View/download PDF
8. The mitochondrial genome of the black-tailed dusky antechinus ( Antechinus arktos ).
- Author
-
Geng Y, Yang C, Guo H, Thomas PB, Jeffery PL, Chopin LK, Baker AM, Tian R, and Seim I
- Abstract
In this study, we report the mitochondrial genome of the black-tailed antechinus ( Antechinus arktos ), a recently-discovered, endangered carnivorous marsupial inhabiting a caldera that straddles the border of Australia's mid-east coast. The circular A. arktos genome is 17,334 bp in length and has an AT content of 63.3%. Its gene content and arrangement are consistent with reported marsupial mitogenome assemblies., Competing Interests: No potential conflict of interest was reported by the author(s)., (© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.)
- Published
- 2020
- Full Text
- View/download PDF
9. The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth.
- Author
-
Thomas PB, Seim I, Jeffery PL, Gahete MD, Maugham M, Crisp GJ, Stacey A, Shah ET, Walpole C, Whiteside EJ, Nelson CC, Herington AC, Luque RM, Veedu RN, and Chopin LK
- Subjects
- Animals, Apoptosis genetics, Breast pathology, Breast Neoplasms immunology, Breast Neoplasms pathology, Disease Progression, Down-Regulation, Female, Gene Expression Profiling, Histocompatibility Antigens Class II genetics, Histocompatibility Antigens Class II immunology, Humans, MCF-7 Cells, Mice, Middle Aged, Oligonucleotide Array Sequence Analysis, Receptors, Ghrelin genetics, Tumor Escape genetics, Xenograft Model Antitumor Assays, Breast Neoplasms genetics, Cell Movement genetics, Gene Expression Regulation, Neoplastic, RNA, Long Noncoding metabolism
- Abstract
Recent evidence suggests that numerous long non‑coding RNAs (lncRNAs) are dysregulated in cancer, and have critical roles in tumour development and progression. The present study investigated the ghrelin receptor antisense lncRNA growth hormone secretagogue receptor opposite strand (GHSROS) in breast cancer. Reverse transcription‑quantitative polymerase chain reaction revealed that GHSROS expression was significantly upregulated in breast tumour tissues compared with normal breast tissue. Induced overexpression of GHSROS in the MDA‑MB‑231 breast cancer cell line significantly increased cell migration in vitro, without affecting cell proliferation, a finding similar to our previous study on lung cancer cell lines. Microarray analysis revealed a significant repression of a small cluster of major histocompatibility class II genes and enrichment of immune response pathways; this phenomenon may allow tumour cells to better evade the immune system. Ectopic overexpression of GHSROS in the MDA‑MB‑231 cell line significantly increased orthotopic xenograft growth in mice, suggesting that in vitro culture does not fully capture the function of this lncRNA. This study demonstrated that GHSROS may serve a relevant role in breast cancer. Further studies are warranted to explore the function and therapeutic potential of this lncRNA in breast cancer progression.
- Published
- 2019
- Full Text
- View/download PDF
10. The mitochondrial genome of the black-tailed dasyure ( Murexia melanurus ).
- Author
-
Tian R, Geng Y, Thomas PB, Jeffery PL, Mutton TY, Chopin LK, Baker AM, and Seim I
- Abstract
In this study, we report the mitochondrial genome of the black-tailed dasyure ( Murexia melanurus ) of New Guinea. The circular genome is 17,736 bp in length and has an AT content of 60.5%. Its gene content - 13 protein-coding genes (PCGs), 2 ribosomal (rRNA) genes, 21 transfer RNA (tRNA) genes, a tRNA pseudogene ( tRNA
Lys ), and a non-coding control region (CR) - and gene arrangement are consistent with previous marsupial mitogenome assemblies., Competing Interests: The authors declare that they have no competing interests., (© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.)- Published
- 2019
- Full Text
- View/download PDF
11. Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys 3 ]-GHRP-6.
- Author
-
Maugham ML, Seim I, Thomas PB, Crisp GJ, Shah ET, Herington AC, Gregory LS, Nelson CC, Jeffery PL, and Chopin LK
- Subjects
- Animals, ErbB Receptors metabolism, Heterografts, Humans, Male, Mice, Mice, Inbred NOD, Mice, SCID, PC-3 Cells, Prostatic Neoplasms genetics, Prostatic Neoplasms metabolism, Cell Proliferation drug effects, ErbB Receptors genetics, Gene Expression drug effects, Oligopeptides pharmacology, Prostatic Neoplasms pathology, Receptors, Ghrelin antagonists & inhibitors
- Abstract
Purpose: The ghrelin axis regulates many physiological functions (including appetite, metabolism, and energy balance) and plays a role in disease processes. As ghrelin stimulates prostate cancer proliferation, the ghrelin receptor antagonist [D-Lys
3 ]-GHRP-6 is a potential treatment for castrate-resistant prostate cancer and for preventing the metabolic consequences of androgen-targeted therapies. We therefore explored the effect of [D-Lys3 ]-GHRP-6 on PC3 prostate cancer xenograft growth., Methods: NOD/SCID mice with PC3 prostate cancer xenografts were administered 20 nmoles/mouse [D-Lys3 ]-GHRP-6 daily by intraperitoneal injection for 14 days and tumour volume and weight were measured. RNA sequencing of tumours was conducted to investigate expression changes following [D-Lys3 ]-GHRP-6 treatment. A second experiment, extending treatment time to 18 days and including a higher dose of [D-Lys3 ]-GHRP-6 (200 nmoles/mouse/day), was undertaken to ensure repeatability., Results: We demonstrate here that daily intraperitoneal injection of 20 nmoles/mouse [D-Lys3 ]-GHRP-6 reduces PC3 prostate cancer xenograft tumour volume and weight in NOD/SCID mice at two weeks post treatment initiation. RNA-sequencing revealed reduced expression of epidermal growth factor receptor (EGFR) in these tumours. Further experiments demonstrated that the effects of [D-Lys3 ]-GHRP-6 are transitory and lost after 18 days of treatment., Conclusions: We show that [D-Lys3 ]-GHRP-6 has transitory effects on prostate xenograft tumours in mice, which rapidly develop an apparent resistance to the antagonist. Although further studies on [D-Lys3 ]-GHRP-6 are warranted, we suggest that daily treatment with the antagonist is not a suitable treatment for advanced prostate cancer.- Published
- 2019
- Full Text
- View/download PDF
12. RadAA: A Command-line Tool for Identification of Radical Amino Acid Changes in Multiple Sequence Alignments.
- Author
-
Seim I, Baker AM, and Chopin LK
- Subjects
- Amino Acid Substitution, Animals, Humans, Sequence Alignment methods, Sequence Analysis, Protein methods, Software
- Abstract
High-throughput sequencing has revolutionised biology and medicine. Numerous genomes and transcriptome assemblies are now available, and these genomic data sets lend themselves to comparisons between species, strains, and other strata. Researchers often need to rapidly identify changes, in particular amino acid substitutions that could confer biological function in their system of interest. However, we are not aware of an easy-to-use tool that can be used to detect such changes, and researchers currently rely on idiosyncratic computer code. We present RadAA, a command-line tool which screens multiple sequence alignments for radical amino acid changes in a stratum/strata by classifying residues into groups by charge (with cysteine in its own group). RadAA is easy to use, even for researchers with little experience in computational biology. It can be run on most operating systems - including MacOS, Windows, and Linux - and integrated into high-performance computing environments. The RadAA source code and executable binaries are freely available at https://github.com/sciseim/RadAA., (© 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.)
- Published
- 2019
- Full Text
- View/download PDF
13. No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunction.
- Author
-
Maugham ML, Seim I, Thomas PB, Crisp GJ, Shah ET, Herington AC, Brown KA, Gregory LS, Nelson CC, Jeffery PL, and Chopin LK
- Subjects
- Animals, Blood Glucose, Cell Line, Tumor, Diet, High-Fat, Ghrelin therapeutic use, Heterografts, Homeodomain Proteins genetics, Humans, Hyperinsulinism metabolism, Male, Mice, Mice, Knockout, Obesity metabolism, Prostatic Neoplasms complications, Prostatic Neoplasms metabolism, Ghrelin pharmacology, Homeodomain Proteins metabolism, Hyperinsulinism complications, Obesity complications, Prostatic Neoplasms drug therapy
- Abstract
Ghrelin is a peptide hormone which, when acylated, regulates appetite, energy balance and a range of other biological processes. Ghrelin predominately circulates in its unacylated form (unacylated ghrelin; UAG). UAG has a number of functions independent of acylated ghrelin, including modulation of metabolic parameters and cancer progression. UAG has also been postulated to antagonise some of the metabolic effects of acyl-ghrelin, including its effects on glucose and insulin regulation. In this study, Rag1-/- mice with high-fat diet-induced obesity and hyperinsulinaemia were subcutaneously implanted with PC3 prostate cancer xenografts to investigate the effect of UAG treatment on metabolic parameters and xenograft growth. Daily intraperitoneal injection of 100 μg/kg UAG had no effect on xenograft tumour growth in mice fed normal rodent chow or 23% high-fat diet. UAG significantly improved glucose tolerance in host Rag1-/- mice on a high-fat diet, but did not significantly improve other metabolic parameters. We propose that UAG is not likely to be an effective treatment for prostate cancer, with or without associated metabolic syndrome., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
14. Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines.
- Author
-
Seim I, Jeffery PL, Thomas PB, Nelson CC, and Chopin LK
- Subjects
- Cell Line, Tumor, Computational Biology methods, DNA Copy Number Variations, Databases, Nucleic Acid, Genomics methods, Humans, INDEL Mutation, Male, Neoplasm Metastasis, Polymorphism, Single Nucleotide, Prostatic Neoplasms mortality, Prostatic Neoplasms pathology, Genome, Human, Genome-Wide Association Study, Prostatic Neoplasms genetics, Whole Genome Sequencing
- Abstract
The bone metastasis-derived PC3 and the lymph node metastasis-derived LNCaP prostate cancer cell lines are widely studied, having been described in thousands of publications over the last four decades. Here, we report short-read whole-genome sequencing (WGS) and de novo assembly of PC3 (ATCC CRL-1435) and LNCaP (clone FGC; ATCC CRL-1740) at ∼70 × coverage. A known homozygous mutation in TP53 and homozygous loss of PTEN were robustly identified in the PC3 cell line, whereas the LNCaP cell line exhibited a larger number of putative inactivating somatic point and indel mutations (and in particular a loss of stop codon events). This study also provides preliminary evidence that loss of one or both copies of the tumor suppressor Capicua ( CIC ) contributes to primary tumor relapse and metastatic progression, potentially offering a treatment target for castration-resistant prostate cancer (CRPC). Our work provides a resource for genetic, genomic, and biological studies employing two commonly-used prostate cancer cell lines., (Copyright © 2017 Seim et al.)
- Published
- 2017
- Full Text
- View/download PDF
15. Insights from engraftable immunodeficient mouse models of hyperinsulinaemia.
- Author
-
Maugham ML, Thomas PB, Crisp GJ, Philp LK, Shah ET, Herington AC, Chen C, Gregory LS, Nelson CC, Seim I, Jeffery PL, and Chopin LK
- Subjects
- Adipose Tissue metabolism, Animals, Blood Glucose, Body Weight, Diet, High-Fat, Female, Heterografts, Homeodomain Proteins genetics, Humans, Hyperinsulinism immunology, Insulin blood, Insulin metabolism, Liver metabolism, Male, Mice, Mice, Inbred NOD, Mice, Knockout, Mice, SCID, Muscle, Skeletal metabolism, Organ Specificity, Pancreas metabolism, Disease Models, Animal, Disease Susceptibility, Hyperinsulinism etiology, Hyperinsulinism metabolism
- Abstract
Hyperinsulinaemia, obesity and dyslipidaemia are independent and collective risk factors for many cancers. Here, the long-term effects of a 23% Western high-fat diet (HFD) in two immunodeficient mouse strains (NOD/SCID and Rag1
-/- ) suitable for engraftment with human-derived tissue xenografts, and the effect of diet-induced hyperinsulinaemia on human prostate cancer cell line xenograft growth, were investigated. Rag1-/- and NOD/SCID HFD-fed mice demonstrated diet-induced impairments in glucose tolerance at 16 and 23 weeks post weaning. Rag1-/- mice developed significantly higher fasting insulin levels (2.16 ± 1.01 ng/ml, P = 0.01) and increased insulin resistance (6.70 ± 1.68 HOMA-IR, P = 0.01) compared to low-fat chow-fed mice (0.71 ± 0.12 ng/ml and 2.91 ± 0.42 HOMA-IR). This was not observed in the NOD/SCID strain. Hepatic steatosis was more extensive in Rag1-/- HFD-fed mice compared to NOD/SCID mice. Intramyocellular lipid storage was increased in Rag1-/- HFD-fed mice, but not in NOD/SCID mice. In Rag1-/- HFD-fed mice, LNCaP xenograft tumours grew more rapidly compared to low-fat chow-fed mice. This is the first characterisation of the metabolic effects of long-term Western HFD in two mouse strains suitable for xenograft studies. We conclude that Rag1-/- mice are an appropriate and novel xenograft model for studying the relationship between cancer and hyperinsulinaemia.- Published
- 2017
- Full Text
- View/download PDF
16. Multi-species sequence comparison reveals conservation of ghrelin gene-derived splice variants encoding a truncated ghrelin peptide.
- Author
-
Seim I, Jeffery PL, Thomas PB, Walpole CM, Maugham M, Fung JN, Yap PY, O'Keeffe AJ, Lai J, Whiteside EJ, Herington AC, and Chopin LK
- Subjects
- Amino Acid Sequence, Animals, Appetite Regulation drug effects, Cell Movement drug effects, Cell Proliferation drug effects, Cells, Cultured, Conserved Sequence, Ghrelin pharmacology, Humans, Male, Mice, Mice, Inbred C57BL, Protein Isoforms genetics, Protein Isoforms pharmacology, Species Specificity, Alternative Splicing, Ghrelin genetics
- Abstract
The peptide hormone ghrelin is a potent orexigen produced predominantly in the stomach. It has a number of other biological actions, including roles in appetite stimulation, energy balance, the stimulation of growth hormone release and the regulation of cell proliferation. Recently, several ghrelin gene splice variants have been described. Here, we attempted to identify conserved alternative splicing of the ghrelin gene by cross-species sequence comparisons. We identified a novel human exon 2-deleted variant and provide preliminary evidence that this splice variant and in1-ghrelin encode a C-terminally truncated form of the ghrelin peptide, termed minighrelin. These variants are expressed in humans and mice, demonstrating conservation of alternative splicing spanning 90 million years. Minighrelin appears to have similar actions to full-length ghrelin, as treatment with exogenous minighrelin peptide stimulates appetite and feeding in mice. Forced expression of the exon 2-deleted preproghrelin variant mirrors the effect of the canonical preproghrelin, stimulating cell proliferation and migration in the PC3 prostate cancer cell line. This is the first study to characterise an exon 2-deleted preproghrelin variant and to demonstrate sequence conservation of ghrelin gene-derived splice variants that encode a truncated ghrelin peptide. This adds further impetus for studies into the alternative splicing of the ghrelin gene and the function of novel ghrelin peptides in vertebrates.
- Published
- 2016
- Full Text
- View/download PDF
17. Reproducibility of scratch assays is affected by the initial degree of confluence: Experiments, modelling and model selection.
- Author
-
Jin W, Shah ET, Penington CJ, McCue SW, Chopin LK, and Simpson MJ
- Subjects
- Biological Assay methods, Cell Count, Cell Line, Tumor, Humans, Reproducibility of Results, Stress, Mechanical, Time Factors, Algorithms, Cell Movement physiology, Cell Proliferation physiology, Models, Biological
- Abstract
Scratch assays are difficult to reproduce. Here we identify a previously overlooked source of variability which could partially explain this difficulty. We analyse a suite of scratch assays in which we vary the initial degree of confluence (initial cell density). Our results indicate that the rate of re-colonisation is very sensitive to the initial density. To quantify the relative roles of cell migration and proliferation, we calibrate the solution of the Fisher-Kolmogorov model to cell density profiles to provide estimates of the cell diffusivity, D, and the cell proliferation rate, λ. This procedure indicates that the estimates of D and λ are very sensitive to the initial density. This dependence suggests that the Fisher-Kolmogorov model does not accurately represent the details of the collective cell spreading process, since this model assumes that D and λ are constants that ought to be independent of the initial density. Since higher initial cell density leads to enhanced spreading, we also calibrate the solution of the Porous-Fisher model to the data as this model assumes that the cell flux is an increasing function of the cell density. Estimates of D and λ associated with the Porous-Fisher model are less sensitive to the initial density, suggesting that the Porous-Fisher model provides a better description of the experiments., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
18. Effect of Deletion of Ghrelin-O-Acyltransferase on the Pulsatile Release of Growth Hormone in Mice.
- Author
-
Xie TY, Ngo ST, Veldhuis JD, Jeffery PL, Chopin LK, Tschöp M, Waters MJ, Tolle V, Epelbaum J, Chen C, and Steyn FJ
- Subjects
- Acyltransferases genetics, Animals, Growth Hormone-Releasing Hormone biosynthesis, Hypothalamus metabolism, Insulin-Like Growth Factor I metabolism, Male, Membrane Proteins, Mice, Mice, Knockout, Neuropeptide Y biosynthesis, Receptors, Ghrelin biosynthesis, Somatostatin biosynthesis, Acyltransferases deficiency, Acyltransferases physiology, Growth Hormone metabolism
- Abstract
Ghrelin, a gut hormone originating from the post-translational cleavage of preproghrelin, is the endogenous ligand of growth hormone secretagogue receptor 1a (GHS-R1a). Within the growth hormone (GH) axis, the biological activity of ghrelin requires octanoylation by ghrelin-O-acyltransferase (GOAT), conferring selective binding to the GHS-R1a receptor via acylated ghrelin. Complete loss of preproghrelin-derived signalling (through deletion of the Ghrl gene) contributes to a decline in peak GH release; however, the selective contribution of endogenous acyl-ghrelin to pulsatile GH release remains to be established. We assessed the pulsatile release of GH in ad lib. fed male germline goat(-/-) mice, extending measures to include mRNA for key hypothalamic regulators of GH release, and peripheral factors that are modulated relative to GH release. The amount of GH released was reduced in young goat(-/-) mice compared to age-matched wild-type mice, whereas pulse frequency and irregularity increased. Altered GH release did not coincide with alterations in hypothalamic Ghrh, Srif, Npy or Ghsr mRNA expression, or pituitary GH content, suggesting that loss of Goat does not compromise canonical mechanisms that contribute to pituitary GH production and release. Although loss of Goat resulted in an irregular pattern of GH release (characterised by an increase in the number of GH pulses observed during extended secretory events), this did not contribute to a change in the expression of sexually dimorphic GH-dependent liver genes. Of interest, circulating levels of insulin-like growth factor (IGF)-1 were elevated in goat(-/-) mice. This rise in circulating levels of IGF-1 was correlated with an increase in GH pulse frequency, suggesting that sustained or increased IGF-1 release in goat(-/-) mice may occur in response to altered GH release patterning. Our observations demonstrate that germline loss of Goat alters GH release and patterning. Although the biological relevance of altered GH secretory patterning remains unclear, we propose that this may contribute to sustained IGF-1 release and growth in goat(-/-) mice., (© 2015 British Society for Neuroendocrinology.)
- Published
- 2015
- Full Text
- View/download PDF
19. Estimating cell diffusivity and cell proliferation rate by interpreting IncuCyte ZOOM™ assay data using the Fisher-Kolmogorov model.
- Author
-
Johnston ST, Shah ET, Chopin LK, Sean McElwain DL, and Simpson MJ
- Subjects
- Cell Line, Tumor, Humans, Cell Movement, Cell Proliferation, Diffusion, Models, Biological
- Abstract
Background: Standard methods for quantifying IncuCyte ZOOM(™) assays involve measurements that quantify how rapidly the initially-vacant area becomes re-colonised with cells as a function of time. Unfortunately, these measurements give no insight into the details of the cellular-level mechanisms acting to close the initially-vacant area. We provide an alternative method enabling us to quantify the role of cell motility and cell proliferation separately. To achieve this we calibrate standard data available from IncuCyte ZOOM(™) images to the solution of the Fisher-Kolmogorov model., Results: The Fisher-Kolmogorov model is a reaction-diffusion equation that has been used to describe collective cell spreading driven by cell migration, characterised by a cell diffusivity, D, and carrying capacity limited proliferation with proliferation rate, λ, and carrying capacity density, K. By analysing temporal changes in cell density in several subregions located well-behind the initial position of the leading edge we estimate λ and K. Given these estimates, we then apply automatic leading edge detection algorithms to the images produced by the IncuCyte ZOOM(™) assay and match this data with a numerical solution of the Fisher-Kolmogorov equation to provide an estimate of D. We demonstrate this method by applying it to interpret a suite of IncuCyte ZOOM(™) assays using PC-3 prostate cancer cells and obtain estimates of D, λ and K. Comparing estimates of D, λ and K for a control assay with estimates of D, λ and K for assays where epidermal growth factor (EGF) is applied in varying concentrations confirms that EGF enhances the rate of scratch closure and that this stimulation is driven by an increase in D and λ, whereas K is relatively unaffected by EGF., Conclusions: Our approach for estimating D, λ and K from an IncuCyte ZOOM(™) assay provides more detail about cellular-level behaviour than standard methods for analysing these assays. In particular, our approach can be used to quantify the balance of cell migration and cell proliferation and, as we demonstrate, allow us to quantify how the addition of growth factors affects these processes individually.
- Published
- 2015
- Full Text
- View/download PDF
20. Comparative analysis reveals loss of the appetite-regulating peptide hormone ghrelin in falcons.
- Author
-
Seim I, Jeffery PL, Herington AC, and Chopin LK
- Subjects
- Amino Acid Sequence, Animals, Molecular Sequence Data, Phylogeny, Sequence Homology, Amino Acid, Appetite Regulation physiology, Falconiformes physiology, Ghrelin metabolism, Peptide Hormones metabolism
- Abstract
Ghrelin and leptin are key peripherally secreted appetite-regulating hormones in vertebrates. Here we consider the ghrelin gene (GHRL) of birds (class Aves), where it has been reported that ghrelin inhibits rather than augments feeding. Thirty-one bird species were compared, revealing that most species harbour a functional copy of GHRL and the coding region for its derived peptides ghrelin and obestatin. We provide evidence for loss of GHRL in saker and peregrine falcons, and this is likely to result from the insertion of an ERVK retrotransposon in intron 0. We hypothesise that the loss of anorexigenic ghrelin is a predatory adaptation that results in increased food-seeking behaviour and feeding in falcons., (Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
21. Associations between ghrelin and ghrelin receptor polymorphisms and cancer in Caucasian populations: a meta-analysis.
- Author
-
Pabalan NA, Seim I, Jarjanazi H, and Chopin LK
- Subjects
- Colorectal Neoplasms genetics, Esophageal Neoplasms genetics, Humans, Lymphoma, Non-Hodgkin genetics, Breast Neoplasms genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
- Abstract
Background: There is growing evidence that the ghrelin axis, including ghrelin (GHRL) and its receptor, the growth hormone secretagogue receptor (GHSR), play a role in cancer progression. Ghrelin gene and ghrelin receptor gene polymorphisms have been reported to have a range of effects in cancer, from increased risk, to protection from cancer, or having no association. In this study we aimed to clarify the role of ghrelin and ghrelin receptor polymorphisms in cancer by performing a meta-analysis of published case-control studies., Results: In the overall analysis, homozygous and recessive associations indicated that the minor alleles of rs696217 and rs2075356 GHRL polymorphisms conferred reduced cancer risk (odds ratio [OR] 0.61-0.78). The risk was unchanged for breast cancer patients when analysed separately (OR 0.73-0.83). In contrast, the rs4684677 GHRL and the rs572169 GHSR polymorphisms conferred increased breast cancer risk (OR 1.97-1.98, p = 0.08 and OR 1.42-1.43, p = 0.08, respectively). All dominant and co-dominant effects showed null effects (OR 0.96-1.05), except for the rs572169 co-dominant effect, with borderline increased risk (OR 1.08, p = 0.05)., Conclusions: This study suggests that the rs696217 and rs2075356 ghrelin gene (GHRL) polymorphisms may protect carriers against breast cancer, and the rs4684677 GHRL and rs572169 GHSR polymorphisms may increase the risk among carriers. In addition, larger studies are required to confirm these findings.
- Published
- 2014
- Full Text
- View/download PDF
22. Cloning and tissue distribution of novel splice variants of the ovine ghrelin gene.
- Author
-
Menzies M, Seim I, Josh P, Nagaraj SH, Lees M, Walpole C, Chopin LK, Colgrave M, and Ingham A
- Subjects
- Amino Acid Sequence, Animals, Gene Expression Regulation, Genetic Predisposition to Disease, Ghrelin genetics, Haemonchiasis genetics, Haemonchiasis metabolism, Haemonchus, Leukocytes metabolism, Molecular Sequence Data, Protein Isoforms, Sheep, Sheep Diseases genetics, Cloning, Molecular, Ghrelin metabolism, Haemonchiasis veterinary, Sheep Diseases metabolism
- Abstract
Background: The ghrelin axis is involved in the regulation of metabolism, energy balance, and the immune, cardiovascular and reproductive systems. The manipulation of this axis has potential for improving economically valuable traits in production animals, and polymorphisms in the ghrelin (GHRL) and ghrelin receptor (GHSR) genes have been associated with growth and carcass traits. Here we investigate the structure and expression of the ghrelin gene (GHRL) in sheep, Ovis aries., Results: We identify two ghrelin mRNA isoforms, which we have designated Δex2 preproghrelin and Δex2,3 preproghrelin. Expression of Δex2,3 preproghrelin is likely to be restricted to ruminants, and would encode truncated ghrelin and a novel C-terminal peptide. Both Δex2 preproghrelin and canonical preproghrelin mRNA isoforms were expressed in a range of tissues. Expression of the Δex2,3 preproghrelin isoform, however, was restricted to white blood cells (WBC; where the wild-type preproghrelin isoform is not co-expressed), and gastrointestinal tissues. Expression of Δex2 preproghrelin and Δex2,3 preproghrelin mRNA was elevated in white blood cells in response to parasitic worm (helminth) infection in genetically susceptible sheep, but not in resistant sheep., Conclusions: The restricted expression of the novel preproghrelin variants and their distinct WBC expression pattern during parasite infection may indicate a novel link between the ghrelin axis and metabolic and immune function in ruminants.
- Published
- 2014
- Full Text
- View/download PDF
23. Turtle ghrelin.
- Author
-
Seim I, Jeffery PL, Herington AC, and Chopin LK
- Subjects
- Animals, Turtles genetics
- Published
- 2014
- Full Text
- View/download PDF
24. Identification of a long non-coding RNA gene, growth hormone secretagogue receptor opposite strand, which stimulates cell migration in non-small cell lung cancer cell lines.
- Author
-
Whiteside EJ, Seim I, Pauli JP, O'Keeffe AJ, Thomas PB, Carter SL, Walpole CM, Fung JN, Josh P, Herington AC, and Chopin LK
- Subjects
- Base Sequence, Carcinogenesis genetics, Carcinoma, Non-Small-Cell Lung genetics, Cell Line, Tumor, Cell Movement genetics, Cell Proliferation, Gene Expression Regulation, Neoplastic, Humans, Lung Neoplasms genetics, Neoplasm Metastasis, Sequence Analysis, DNA, Transfection, Carcinoma, Non-Small-Cell Lung pathology, Lung Neoplasms pathology, RNA, Long Noncoding genetics, Receptors, Ghrelin genetics
- Abstract
The molecular mechanisms involved in non‑small cell lung cancer tumourigenesis are largely unknown; however, recent studies have suggested that long non-coding RNAs (lncRNAs) are likely to play a role. In this study, we used public databases to identify an mRNA-like, candidate long non-coding RNA, GHSROS (GHSR opposite strand), transcribed from the antisense strand of the ghrelin receptor gene, growth hormone secretagogue receptor (GHSR). Quantitative real-time RT-PCR revealed higher expression of GHSROS in lung cancer tissue compared to adjacent, non-tumour lung tissue. In common with many long non-coding RNAs, GHSROS is 5' capped and 3' polyadenylated (mRNA-like), lacks an extensive open reading frame and harbours a transposable element. Engineered overexpression of GHSROS stimulated cell migration in the A549 and NCI-H1299 non-small cell lung cancer cell lines, but suppressed cell migration in the Beas-2B normal lung-derived bronchoepithelial cell line. This suggests that GHSROS function may be dependent on the oncogenic context. The identification of GHSROS, which is expressed in lung cancer and stimulates cell migration in lung cancer cell lines, contributes to the growing number of non-coding RNAs that play a role in the regulation of tumourigenesis and metastatic cancer progression.
- Published
- 2013
- Full Text
- View/download PDF
25. Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitro by ghrelin.
- Author
-
Seim I, Jeffery PL, de Amorim L, Walpole CM, Fung J, Whiteside EJ, Lourie R, Herington AC, and Chopin LK
- Subjects
- Acyltransferases metabolism, Cell Line, Cell Line, Tumor, Furin genetics, Furin metabolism, Gene Expression Regulation, Enzymologic drug effects, Humans, Immunohistochemistry, Male, Proprotein Convertase 1 genetics, Proprotein Convertase 1 metabolism, Proprotein Convertase 2 genetics, Proprotein Convertase 2 metabolism, Prostate enzymology, Prostate metabolism, Prostatic Neoplasms metabolism, Prostatic Neoplasms pathology, Reverse Transcriptase Polymerase Chain Reaction, Acyltransferases genetics, Gene Expression Regulation, Neoplastic, Ghrelin pharmacology, Prostatic Neoplasms genetics
- Abstract
Background: Ghrelin is a 28 amino acid peptide hormone that is expressed in the stomach and a range of peripheral tissues, where it frequently acts as an autocrine/paracrine growth factor. Ghrelin is modified by a unique acylation required for it to activate its cognate receptor, the growth hormone secretagogue receptor (GHSR), which mediates many of the actions of ghrelin. Recently, the enzyme responsible for adding the fatty acid residue (octanoyl/acyl group) to the third amino acid of ghrelin, GOAT (ghrelin O-acyltransferase), was identified., Methods: We used cell culture, quantitative real-time reverse transcription (RT)-PCR and immunohistochemistry to demonstrate the expression of GOAT in prostate cancer cell lines and tissues from patients. Real-time RT-PCR was used to demonstrate the expression of prohormone convertase (PC)1/3, PC2 and furin in prostate cancer cell lines. Prostate-derived cell lines were treated with ghrelin and desacyl ghrelin and the effect on GOAT expression was measured using quantitative RT-PCR., Results: We have demonstrated that GOAT mRNA and protein are expressed in the normal prostate and human prostate cancer tissue samples. The RWPE-1 and RWPE-2 normal prostate-derived cell lines and the LNCaP, DU145, and PC3 prostate cancer cell lines express GOAT and at least one other enzyme that is necessary to produce mature, acylated ghrelin from proghrelin (PC1/3, PC2 or furin). Finally, ghrelin, but not desacyl ghrelin (unacylated ghrelin), can directly regulate the expression of GOAT in the RWPE-1 normal prostate derived cell line and the PC3 prostate cancer cell line. Ghrelin treatment (100nM) for 6 hours significantly decreased GOAT mRNA expression two-fold (P < 0.05) in the PC3 prostate cancer cell line, however, ghrelin did not regulate GOAT expression in the DU145 and LNCaP prostate cancer cell lines., Conclusions: This study demonstrates that GOAT is expressed in prostate cancer specimens and cell lines. Ghrelin regulates GOAT expression, however, this is likely to be cell-type specific. The expression of GOAT in prostate cancer supports the hypothesis that the ghrelin axis has autocrine/paracrine roles. We propose that the RWPE-1 prostate cell line and the PC3 prostate cancer cell line may be useful for investigating GOAT regulation and function.
- Published
- 2013
- Full Text
- View/download PDF
26. Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo.
- Author
-
Fung JN, Jeffery PL, Lee JD, Seim I, Roche D, Obermair A, Chopin LK, and Chen C
- Subjects
- Animals, Blotting, Western, Cell Line, Tumor, Cell Proliferation, Disease Progression, Female, Flow Cytometry, Gene Silencing, Genetic Vectors, Ghrelin metabolism, Humans, Immunohistochemistry, Lentivirus genetics, Mice, Mice, Inbred NOD, Microarray Analysis, RNA, Small Interfering pharmacology, Real-Time Polymerase Chain Reaction, Tetrazolium Salts, Thiazoles, Xenograft Model Antitumor Assays, Endometrial Neoplasms genetics, Endometrial Neoplasms pathology, Receptors, Ghrelin genetics
- Abstract
Ghrelin is a 28-amino acid peptide hormone produced predominantly in the stomach but also in a range of normal cell types and tumors, where it has endocrine, paracrine, and autocrine roles. Previously, we have demonstrated that ghrelin has proliferative and antiapoptotic effects in endometrial cancer cell lines, suggesting a potential role in promoting tumor growth. In the present study, we investigated the effect of ghrelin receptor, GHSR, and gene silencing in vitro and in vivo and characterized ghrelin and GHSR1a protein expression in human endometrial tumors. GHSR gene silencing was achieved in the Ishikawa and KLE endometrial cancer cell lines, using a lentiviral short-hairpin RNA targeting GHSR. The effects of GHSR1a knockdown were further analyzed in vivo using the Ishikawa cell line in a NOD/SCID xenograft model. Cell proliferation was reduced in cultured GHSR1a knockdown Ishikawa and KLE cells compared with scrambled controls in the absence of exogenously applied ghrelin and in response to exogenous ghrelin (1,000 nM). The tumor volumes were reduced significantly in GHSR1a knockdown Ishikawa mouse xenograft tumors compared with scrambled control tumours. Using immunohistochemistry, we demonstrated that ghrelin and GHSR1a are expressed in benign and cancerous glands in human endometrial tissue specimens, although there was no correlation between the intensity of staining and cancer grade. These data indicate that downregulation of GHSR expression significantly inhibits endometrial cancer cell line and mouse xenograft tumour growth. This is the first preclinical evidence that downregulation of GHSR may be therapeutic in endometrial cancer.
- Published
- 2013
- Full Text
- View/download PDF
27. Cloning of a novel insulin-regulated ghrelin transcript in prostate cancer.
- Author
-
Seim I, Lubik AA, Lehman ML, Tomlinson N, Whiteside EJ, Herington AC, Nelson CC, and Chopin LK
- Subjects
- Amino Acid Sequence, Cell Line, Tumor, Cloning, Molecular, Exons, Gene Expression Profiling, Gene Order, Genetic Loci, Ghrelin chemistry, Humans, Male, Molecular Sequence Data, Organ Specificity, RNA Splicing, Sequence Alignment, Gene Expression Regulation drug effects, Ghrelin genetics, Insulin pharmacology, Prostatic Neoplasms genetics
- Abstract
Ghrelin is a multifunctional hormone, with roles in stimulating appetite and regulating energy balance, insulin secretion and glucose homoeostasis. The ghrelin gene locus (GHRL) is highly complex and gives rise to a range of novel transcripts derived from alternative first exons and internally spliced exons. The wild-type transcript encodes a 117 amino acid preprohormone that is processed to yield the 28 amino acid peptide ghrelin. Here, we identified insulin-responsive transcription corresponding to cryptic exons in intron 2 of the human ghrelin gene. A transcript, termed in2c-ghrelin (intron 2-cryptic), was cloned from the testis and the LNCaP prostate cancer cell line. This transcript may encode an 83 amino acid preproghrelin isoform that codes for ghrelin, but not obestatin. It is expressed in a limited number of normal tissues and in tumours of the prostate, testis, breast and ovary. Finally, we confirmed that in2c-ghrelin transcript expression, as well as the recently described in1-ghrelin transcript, is significantly upregulated by insulin in cultured prostate cancer cells. Metabolic syndrome and hyperinsulinaemia have been associated with prostate cancer risk and progression. This may be particularly significant after androgen deprivation therapy for prostate cancer, which induces hyperinsulinaemia, and this could contribute to castrate-resistant prostate cancer growth. We have previously demonstrated that ghrelin stimulates prostate cancer cell line proliferation in vitro. This study is the first description of insulin regulation of a ghrelin transcript in cancer and should provide further impetus for studies into the expression, regulation and function of ghrelin gene products.
- Published
- 2013
- Full Text
- View/download PDF
28. The ghrelin axis--does it have an appetite for cancer progression?
- Author
-
Chopin LK, Seim I, Walpole CM, and Herington AC
- Subjects
- Animals, Cachexia drug therapy, Cell Line, Tumor, Disease Progression, Ghrelin therapeutic use, Humans, Ghrelin metabolism, Neoplasms metabolism, Receptors, Ghrelin metabolism
- Abstract
Ghrelin, the endogenous ligand for the GH secretagogue receptor (GHSR), is a peptide hormone with diverse physiological roles. Ghrelin regulates GH release, appetite and feeding, gut motility, and energy balance and also has roles in the cardiovascular, immune, and reproductive systems. Ghrelin and the GHSR are expressed in a wide range of normal and tumor tissues, and a fluorescein-labeled, truncated form of ghrelin is showing promise as a biomarker for prostate cancer. Plasma ghrelin levels are generally inversely related to body mass index and are unlikely to be useful as a biomarker for cancer, but may be useful as a marker for cancer cachexia. Some single nucleotide polymorphisms in the ghrelin and GHSR genes have shown associations with cancer risk; however, larger studies are required. Ghrelin regulates processes associated with cancer, including cell proliferation, apoptosis, cell migration, cell invasion, inflammation, and angiogenesis; however, the role of ghrelin in cancer is currently unclear. Ghrelin has predominantly antiinflammatory effects and may play a role in protecting against cancer-related inflammation. Ghrelin and its analogs show promise as treatments for cancer-related cachexia. Further studies using in vivo models are required to determine whether ghrelin has a role in cancer progression.
- Published
- 2012
- Full Text
- View/download PDF
29. Foreword.
- Author
-
Herington AC and Chopin LK
- Subjects
- Animals, Energy Metabolism, Humans, Mice, Publications statistics & numerical data, Ghrelin metabolism
- Published
- 2011
- Full Text
- View/download PDF
30. Expression and in vitro functions of the ghrelin axis in endometrial cancer.
- Author
-
Fung JN, Seim I, Wang D, Obermair A, Chopin LK, and Chen C
- Subjects
- Adult, Aged, Aged, 80 and over, Cell Proliferation, Cell Separation, Female, Humans, Immunoblotting, Middle Aged, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction physiology, Endometrial Neoplasms metabolism, Ghrelin metabolism, Receptors, Ghrelin metabolism
- Abstract
Ghrelin is a peptide hormone produced in the stomach and a range of other tissues, where it has endocrine, paracrine and autocrine roles in both normal and disease states. Ghrelin has been shown to be an important growth factor for a number of tumours, including prostate and breast cancers. In this study, we examined the expression of the ghrelin axis (ghrelin and its receptor, the growth hormone secretagogue receptor, GHSR) in endometrial cancer. Ghrelin is expressed in a range of endometrial cancer tissues, while its cognate receptor, GHSR1a, is expressed in a small subset of normal and cancer tissues. Low to moderately invasive endometrial cancer cell lines were examined by RT-PCR and immunoblotting, demonstrating that ghrelin axis mRNA and protein expression correlate with differentiation status of Ishikawa, HEC1B and KLE endometrial cancer cell lines. Moreover, treatment with ghrelin potently stimulated cell proliferation and inhibited cell death. Taken together, these data indicate that ghrelin promotes the progression of endometrial cancer cells in vitro, and may contribute to endometrial cancer pathogenesis and represent a novel treatment target., (© Springer Science+Business Media, LLC 2010)
- Published
- 2010
- Full Text
- View/download PDF
31. Ghrelin gene-related peptides: multifunctional endocrine / autocrine modulators in health and disease.
- Author
-
Seim I, Amorim L, Walpole C, Carter S, Chopin LK, and Herington AC
- Subjects
- Alternative Splicing, Animals, Appetite Regulation physiology, Eating physiology, Humans, Peptide Hormones genetics, Peptide Hormones physiology, Receptors, Ghrelin genetics, Receptors, Ghrelin metabolism, Gene Expression Regulation physiology, Ghrelin analogs & derivatives, Ghrelin genetics, Ghrelin physiology, Ghrelin therapeutic use, Neoplasms drug therapy, Obesity drug therapy, Peptide Hormones therapeutic use
- Abstract
1. Ghrelin is a multifunctional peptide hormone that affects various processes, including growth hormone and insulin release, appetite regulation, gut motility, metabolism and cancer cell proliferation. Ghrelin is produced in the stomach and in other normal and pathological cell types. It may act as an endocrine or autocrine/paracrine factor. 2. The present article reviews recent findings in the study of ghrelin and its receptor that suggest that the ghrelin gene locus may give rise to a number of functional molecules (peptides and RNA transcripts) in addition to ghrelin. 3. The ghrelin gene encodes a precursor protein, preproghrelin, from which ghrelin and other potentially active peptides are derived by alternative mRNA splicing and/or proteolytic processing. The metabolic role of the peptide obestatin, derived from the preproghrelin C-terminal region, is contentious. However, obestatin has direct effects on cell proliferation. 4. The regulation of ghrelin expression and the mechanisms through which the peptide products arise are unclear. We have recently re-examined the organization of the ghrelin gene and identified several novel exons and transcripts. One transcript, which lacks the ghrelin-coding region of preproghrelin, contains the coding sequence of obestatin. 5. Furthermore, we have identified an overlapping gene on the antisense strand of ghrelin, namely GHRLOS, which generates transcripts that may function as non-coding regulatory RNAs or code for novel, short bioactive peptides. 6. The identification of these novel ghrelin-gene related transcripts and peptides raises critical questions regarding their physiological function and their potential role in obesity, diabetes and cancer.
- Published
- 2010
- Full Text
- View/download PDF
32. New insights into the molecular complexity of the ghrelin gene locus.
- Author
-
Seim I, Herington AC, and Chopin LK
- Subjects
- Animals, Ghrelin metabolism, Humans, Models, Genetic, Protein Isoforms genetics, Protein Isoforms metabolism, Protein Precursors metabolism, Protein Processing, Post-Translational, RNA, Antisense genetics, Transcription, Genetic, Alternative Splicing, Ghrelin genetics, Protein Precursors genetics
- Abstract
Ghrelin is a multi-functional peptide hormone that affects a range of processes, including growth hormone and insulin release, appetite regulation, reproduction, and cancer cell proliferation. The main focus of this review is to advance the hypothesis that the ghrelin gene locus encodes an array of biologically active molecules in addition to ghrelin and is far more complex than currently appreciated. Alternative splicing and the use of alternative post-translational cleavages sites may give rise to novel ghrelin gene-derived peptides that potentially act through different receptors and have novel biological functions.
- Published
- 2009
- Full Text
- View/download PDF
33. The proximal first exon architecture of the murine ghrelin gene is highly similar to its human orthologue.
- Author
-
Seim I, Carter SL, Herington AC, and Chopin LK
- Abstract
Background: The murine ghrelin gene (Ghrl), originally sequenced from stomach tissue, contains five exons and a single transcription start site in a short, 19 bp first exon (exon 0). We recently isolated several novel first exons of the human ghrelin gene and found evidence of a complex transcriptional repertoire. In this report, we examined the 5' exons of the murine ghrelin orthologue in a range of tissues using 5' RACE., Findings: 5' RACE revealed two transcription start sites (TSSs) in exon 0 and four TSSs in intron 0, which correspond to 5' extensions of exon 1. Using quantitative, real-time RT-PCR (qRT-PCR), we demonstrated that extended exon 1 containing Ghrl transcripts are largely confined to the spleen, adrenal gland, stomach, and skin., Conclusion: We demonstrate that multiple transcription start sites are present in exon 0 and an extended exon 1 of the murine ghrelin gene, similar to the proximal first exon organisation of its human orthologue. The identification of several transcription start sites in intron 0 of mouse ghrelin (resulting in an extension of exon 1) raises the possibility that developmental-, cell- and tissue-specific Ghrl mRNA species are created by employing alternative promoters and further studies of the murine ghrelin gene are warranted.
- Published
- 2009
- Full Text
- View/download PDF
34. Complex organisation and structure of the ghrelin antisense strand gene GHRLOS, a candidate non-coding RNA gene.
- Author
-
Seim I, Carter SL, Herington AC, and Chopin LK
- Subjects
- Alternative Splicing, Cell Line, Exons genetics, Gene Expression Regulation, Humans, Polymorphism, Genetic, RNA, Antisense analysis, RNA, Messenger analysis, RNA, Messenger genetics, Ghrelin genetics, RNA, Antisense genetics
- Abstract
Background: The peptide hormone ghrelin has many important physiological and pathophysiological roles, including the stimulation of growth hormone (GH) release, appetite regulation, gut motility and proliferation of cancer cells. We previously identified a gene on the opposite strand of the ghrelin gene, ghrelinOS (GHRLOS), which spans the promoter and untranslated regions of the ghrelin gene (GHRL). Here we further characterise GHRLOS., Results: We have described GHRLOS mRNA isoforms that extend over 1.4 kb of the promoter region and 106 nucleotides of exon 4 of the ghrelin gene, GHRL. These GHRLOS transcripts initiate 4.8 kb downstream of the terminal exon 4 of GHRL and are present in the 3' untranslated exon of the adjacent gene TATDN2 (TatD DNase domain containing 2). Interestingly, we have also identified a putative non-coding TATDN2-GHRLOS chimaeric transcript, indicating that GHRLOS RNA biogenesis is extremely complex. Moreover, we have discovered that the 3' region of GHRLOS is also antisense, in a tail-to-tail fashion to a novel terminal exon of the neighbouring SEC13 gene, which is important in protein transport. Sequence analyses revealed that GHRLOS is riddled with stop codons, and that there is little nucleotide and amino-acid sequence conservation of the GHRLOS gene between vertebrates. The gene spans 44 kb on 3p25.3, is extensively spliced and harbours multiple variable exons. We have also investigated the expression of GHRLOS and found evidence of differential tissue expression. It is highly expressed in tissues which are emerging as major sites of non-coding RNA expression (the thymus, brain, and testis), as well as in the ovary and uterus. In contrast, very low levels were found in the stomach where sense, GHRL derived RNAs are highly expressed., Conclusion: GHRLOS RNA transcripts display several distinctive features of non-coding (ncRNA) genes, including 5' capping, polyadenylation, extensive splicing and short open reading frames. The gene is also non-conserved, with differential and tissue-restricted expression. The overlapping genomic arrangement of GHRLOS with the ghrelin gene indicates that it is likely to have interesting regulatory and functional roles in the ghrelin axis.
- Published
- 2008
- Full Text
- View/download PDF
35. Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts.
- Author
-
Seim I, Collet C, Herington AC, and Chopin LK
- Subjects
- Amino Acid Sequence, Animals, Ghrelin, Humans, Mice, Molecular Sequence Data, Reverse Transcriptase Polymerase Chain Reaction, Alternative Splicing, Exons, Genome, Human, Peptide Hormones genetics, RNA, Antisense genetics, RNA, Messenger genetics
- Abstract
Background: Ghrelin is a multifunctional peptide hormone expressed in a range of normal tissues and pathologies. It has been reported that the human ghrelin gene consists of five exons which span 5 kb of genomic DNA on chromosome 3 and includes a 20 bp non-coding first exon (20 bp exon 0). The availability of bioinformatic tools enabling comparative analysis and the finalisation of the human genome prompted us to re-examine the genomic structure of the ghrelin locus., Results: We have demonstrated the presence of an additional novel exon (exon -1) and 5' extensions to exon 0 and 1 using comparative in silico analysis and have demonstrated their existence experimentally using RT-PCR and 5' RACE. A revised exon-intron structure demonstrates that the human ghrelin gene spans 7.2 kb and consists of six rather than five exons. Several ghrelin gene-derived splice forms were detected in a range of human tissues and cell lines. We have demonstrated ghrelin gene-derived mRNA transcripts that do not code for ghrelin, but instead may encode the C-terminal region of full-length preproghrelin (C-ghrelin, which contains the coding region for obestatin) and a transcript encoding obestatin-only. Splice variants that differed in their 5' untranslated regions were also found, suggesting a role of these regions in the post-transcriptional regulation of preproghrelin translation. Finally, several natural antisense transcripts, termed ghrelinOS (ghrelin opposite strand) transcripts, were demonstrated via orientation-specific RT-PCR, 5' RACE and in silico analysis of ESTs and cloned amplicons., Conclusion: The sense and antisense alternative transcripts demonstrated in this study may function as non-coding regulatory RNA, or code for novel protein isoforms. This is the first demonstration of putative obestatin and C-ghrelin specific transcripts and these findings suggest that these ghrelin gene-derived peptides may also be produced independently of preproghrelin. This study reveals several novel aspects of the ghrelin gene and suggests that the ghrelin locus is far more complex than previously recognised.
- Published
- 2007
- Full Text
- View/download PDF
36. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines.
- Author
-
Jeffery PL, Murray RE, Yeh AH, McNamara JF, Duncan RP, Francis GD, Herington AC, and Chopin LK
- Subjects
- Amino Acid Sequence, Biomarkers, Tumor analysis, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Breast Neoplasms diagnosis, Breast Neoplasms pathology, Carcinoma diagnosis, Carcinoma pathology, Cell Line, Tumor, Cell Proliferation drug effects, Female, Ghrelin, Humans, Immunohistochemistry, Molecular Sequence Data, Peptide Hormones analysis, Peptide Hormones genetics, Protein Isoforms analysis, Protein Isoforms genetics, RNA, Messenger analysis, RNA, Messenger metabolism, Receptors, G-Protein-Coupled analysis, Receptors, G-Protein-Coupled genetics, Receptors, Ghrelin, Sequence Deletion, Transcription, Genetic, Breast Neoplasms metabolism, Carcinoma metabolism, Peptide Hormones metabolism, Peptide Hormones pharmacology, Peptide Hormones physiology
- Abstract
While oestrogen, progesterone and growth factors, including growth hormone (GH), are clearly implicated in the pathogenesis of breast cancer, there is now evidence that the newly described ghrelin axis is also involved. The aims of this study were to investigate the expression of the ghrelin axis in breast cancer tissues and cell lines and to examine the effect of ghrelin on breast cancer cell proliferation in vitro. Ghrelin and its functional receptor, the growth hormone secretagogue receptor (GHSR) type 1a, were expressed in normal breast tissue and breast cancer specimens and cell lines. In contrast, the truncated GHSR type 1b isoform was exclusively expressed in breast carcinoma, suggesting that it has potential as a diagnostic marker. Ghrelin treatment significantly increases the proliferation of the MDA-MB-435 and MDA-MB-231 breast cancer cell lines in vitro. In addition, we have described the expression of a human preproghrelin isoform, exon 3-deleted preproghrelin, which encodes mature ghrelin plus a novel C-terminal peptide. Quantitative RT-PCR was used to demonstrate that this mRNA isoform is highly expressed in the MDA-MB-435 metastatic breast cancer cell line relative to the benign MCF-10A breast epithelial cell line. The unique C-terminal peptide of exon 3-deleted preproghrelin is expressed in the glandular epithelium of breast cancer tissues, with high-grade carcinoma exhibiting the strongest immunoreactivity. The data presented here suggest that components of the ghrelin axis may represent novel markers for breast cancer and potential therapeutic targets.
- Published
- 2005
- Full Text
- View/download PDF
37. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer.
- Author
-
Yeh AH, Jeffery PL, Duncan RP, Herington AC, and Chopin LK
- Subjects
- Apoptosis, Cell Proliferation, Culture Media, Conditioned, Enzyme Activation drug effects, Exons genetics, Ghrelin, Humans, Male, Peptide Fragments pharmacology, Prostatic Hyperplasia enzymology, Prostatic Hyperplasia genetics, Prostatic Hyperplasia pathology, Prostatic Neoplasms enzymology, Prostatic Neoplasms pathology, Sequence Deletion, Tumor Cells, Cultured, Mitogen-Activated Protein Kinases metabolism, Motilin genetics, Peptide Hormones genetics, Peptide Hormones pharmacology, Prostatic Neoplasms genetics
- Abstract
Purpose: There is evidence that the hormone ghrelin stimulates proliferation in the PC3 prostate cancer cell line although the underlying mechanism(s) remain to be determined. A novel, exon 3-deleted preproghrelin isoform has previously been detected in breast and prostate cancer cells; however, its characterization, expression, and potential function in prostate cancer tissues are unknown., Experimental Design: Expression of ghrelin and exon 3-deleted preproghrelin was investigated in prostate cancer cell lines and tissues by reverse transcription-PCR and immunohistochemistry. Proliferation and apoptosis assays were done in the LNCaP prostate cancer cell line to determine if ghrelin stimulates proliferation and/or cell survival. Stimulation of mitogen-activated protein kinase (MAPK) pathway activation by ghrelin was determined in PC3 and LNCaP cells by immunoblotting with antibodies specific for phosphorylated MAPKs., Results: Prostate cancer tissues display greater immunoreactivity for ghrelin and exon 3-deleted preproghrelin than normal prostate tissues, and prostate cancer cell lines secrete mature ghrelin into conditioned medium. Treatment with ghrelin (10 nmol/L), but not the unique COOH-terminal peptide derived from exon 3-deleted preproghrelin, stimulates proliferation in the LNCaP cells (45.0 +/- 1.7% above control, P < 0.01) and rapidly activates the extracellular signal-regulated kinase-1/2 MAPK pathway in both PC3 and LNCaP cell lines. Ghrelin, however, does not protect prostate cancer cells from apoptosis induced by actinomycin D (1 microg/mL). The MAPK inhibitors PD98059 and U0126 blocked ghrelin-induced MAPK activation, as well as proliferation, in both cell lines., Conclusions: These data suggest that these components of the ghrelin axis may have potential as novel biomarkers and/or adjunctive therapeutic targets for prostate cancer.
- Published
- 2005
- Full Text
- View/download PDF
38. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors.
- Author
-
Gaytan F, Morales C, Barreiro ML, Jeffery P, Chopin LK, Herington AC, Casanueva FF, Aguilar E, Dieguez C, and Tena-Sempere M
- Subjects
- Cervix Uteri embryology, Cervix Uteri metabolism, Endometrium embryology, Endometrium metabolism, Epithelial Cells metabolism, Fallopian Tubes embryology, Female, Humans, Immunohistochemistry, Mullerian Ducts embryology, Ovarian Neoplasms pathology, Ovary embryology, Receptors, Ghrelin, Fallopian Tubes metabolism, Ovarian Neoplasms metabolism, Ovary metabolism, Receptors, G-Protein-Coupled metabolism
- Abstract
Ghrelin, the endogenous ligand of the GH secretagogue receptor (GHS-R), is a newly identified, ubiquitously expressed molecule that has been involved in a wide array of endocrine and nonendocrine functions, including cell proliferation. In this context, our group recently reported the expression of ghrelin and its functional receptor, the GHS-R type 1a, in the human ovary and testis as well as several testicular tumors. Ovarian malignancies, however, remain unexplored. Notably, a vast majority of ovarian tumors derive from the surface epithelium, which originates from the celomic epithelium. Considering the proven expression of ghrelin in the human ovary, and its reported effects in the proliferative activity of different cancer cell lines, we aimed at evaluating whether the ovarian surface epithelium as well as related reproductive structures and tumors are potential targets of ghrelin. To this end, expression of GHS-R1a was analyzed by immunohistochemistry in a panel of normal, metaplastic, and neoplastic tissues. Uniform GHS-R1a immunostaining was detected throughout the ovarian surface epithelium. Likewise, ciliated cells within the fallopian tube epithelium showed strong GHS-R1a expression. In contrast, other celomic derivatives, such as endometrium and endocervix, were negative for GHS-R1a immunoreactivity. In keeping with data from normal tissues, inclusion cysts from the surface epithelium expressed GHS-R1a. Similarly, benign serous tumors resembling fallopian tube epithelium were also positive, whereas serous cystadenocarcinomas showed GHS-R1a expression only in highly differentiated specimens. In contrast, other neoplasms, such as mucinous cystadenomas and cystadenocarcinomas, endometrioid tumors, clear cell carcinomas, and Brenner tumors, did not express GHS-R1a. In conclusion, our results demonstrate that the ovarian surface epithelium and related tumors are potential targets for systemic or locally produced ghrelin because they express the functional type 1a GHS-R. Considering the relevant role of the ovarian surface epithelium in key physiological events (such as ovulation) and neoplastic transformation of the ovary, the potential actions of ghrelin in those phenomena merit further investigation.
- Published
- 2005
- Full Text
- View/download PDF
39. Expression of the ghrelin axis in the mouse: an exon 4-deleted mouse proghrelin variant encodes a novel C terminal peptide.
- Author
-
Jeffery PL, Duncan RP, Yeh AH, Jaskolski RA, Hammond DS, Herington AC, and Chopin LK
- Subjects
- Amino Acid Sequence, Animals, Base Sequence, Blotting, Western, Computer Systems, Gastric Mucosa metabolism, Ghrelin, Immunohistochemistry, Mice, Mice, Inbred Strains, Molecular Sequence Data, Peptide Fragments genetics, Peptide Hormones metabolism, Polymerase Chain Reaction, Protein Precursors metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Receptors, G-Protein-Coupled genetics, Receptors, G-Protein-Coupled metabolism, Receptors, Ghrelin, Sequence Homology, Amino Acid, Tissue Distribution, Exons, Gene Deletion, Gene Expression, Genetic Variation, Peptide Hormones genetics, Protein Precursors genetics
- Abstract
Ghrelin, an n-octanoylated 28-amino-acid peptide capable of inducing GH secretion and food intake in humans and rats, is the endogenous ligand for the GH secretagogue receptor (GHS-R). Here we describe the expression and tissue distribution of the ghrelin/GHS-R axis in the mouse. We also report for the first time the identification of a novel mouse ghrelin mRNA variant in which there is a complete deletion of exon 4. Translation of this variant mRNA yields a protein containing ghrelin and an alternative C-terminal domain with a unique C-terminal peptide sequence. RT-PCR with primers specific for mouse ghrelin was used to demonstrate the mRNA expression of the full preproghrelin transcript and the exon 4-deleted variant in multiple mouse tissues. Real-time PCR was also employed to quantitate mRNA expression of ghrelin, the novel isoform and a previously reported ghrelin gene variant, ghrelin gene-derived transcript. We also demonstrated the tissue expression of the functional GHS-R in the mouse. Immunohistochemistry, employing antibodies raised against the mature human n-octanoylated ghrelin peptide and the putative C-terminal peptide encoded by the exon 4-deleted proghrelin variant, was used to demonstrate protein expression of ghrelin and the variant in multiple mouse tissues including stomach, kidney, and reproductive tissues. The coexpression of ghrelin and its receptor in a wide range of murine tissues suggests varied autocrine/paracrine roles for these peptides. Exon 4-deleted proghrelin, a novel mouse proghrelin isoform with a unique C-terminal peptide sequence, is also widely expressed in the mouse and thus may possess biological activity in these tissues.
- Published
- 2005
- Full Text
- View/download PDF
40. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors.
- Author
-
Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, Pinilla L, Paniagua R, Nistal M, Casanueva FF, Aguilar E, Diéguez C, and Tena-Sempere M
- Subjects
- Adult, Aged, Carcinoma, Embryonal chemistry, Ghrelin, Humans, Immunohistochemistry, Leydig Cell Tumor chemistry, Leydig Cells chemistry, Male, Middle Aged, Peptide Hormones analysis, RNA, Messenger analysis, Receptors, G-Protein-Coupled analysis, Receptors, Ghrelin, Reverse Transcriptase Polymerase Chain Reaction, Seminiferous Tubules chemistry, Seminoma chemistry, Sertoli Cells chemistry, Gene Expression, Peptide Hormones genetics, Receptors, G-Protein-Coupled genetics, Testicular Neoplasms chemistry, Testis chemistry
- Abstract
Ghrelin, the endogenous ligand for the GH secretagogue receptor (GHS-R), has been primarily linked to the central neuroendocrine regulation of GH secretion and food intake, although additional peripheral actions of ghrelin have also been reported. In this context, the expression of ghrelin and its cognate receptor has been recently demonstrated in rat testis, suggesting a role for this molecule in the direct control of male gonadal function. However, whether this signaling system is present in human testis remains largely unexplored. In this study we report the expression and cellular location of ghrelin and its functional receptor, the type 1a GHS-R, in adult human testis. In addition, evaluation of ghrelin and GHS-R1a immunoreactivity in testicular tumors and dysgenetic tissue is presented. The expression of the mRNAs encoding ghrelin and GHS-R1a was demonstrated in human testis specimens by RT-PCR, followed by direct sequencing. In normal testis, ghrelin immunostaining was demonstrated in interstitial Leydig cells and, at lower intensity, in Sertoli cells within the seminiferous tubules. In contrast, ghrelin was not detected in germ cells at any stage of spermatogenesis. The cognate ghrelin receptor showed a wider pattern of cellular distribution, with detectable GHS-R1a protein in germ cells, mainly in pachytene spermatocytes, as well as in somatic Sertoli and Leydig cells. Ghrelin immunoreactivity was absent in poorly differentiated Leydig cell tumor, which retained the expression of GHS-R1a peptide. In contrast, highly differentiated Leydig cell tumors expressed both the ligand and the receptor. The expression of ghrelin and GHS-R1a was also detected in dysgenetic Sertoli cell-only seminiferous tubules, whereas germ cell tumors (seminoma and embryonal carcinoma) were negative for ghrelin and were weakly positive for GHS-R1a. In conclusion, our results demonstrate that ghrelin and the type 1a GHS-R are expressed in adult human testis and testicular tumors. Overall, the expression of ghrelin and its functional receptor in human and rat testis, with roughly similar patterns of cellular distribution, is highly suggestive of a conserved role for this newly discovered molecule in the regulation of mammalian testicular function.
- Published
- 2004
- Full Text
- View/download PDF
41. Developmental, stage-specific, and hormonally regulated expression of growth hormone secretagogue receptor messenger RNA in rat testis.
- Author
-
Barreiro ML, Suominen JS, Gaytán F, Pinilla L, Chopin LK, Casanueva FF, Diéguez C, Aguilar E, Toppari J, and Tena-Sempere M
- Subjects
- Animals, Ghrelin, Gonadotropins metabolism, In Situ Hybridization, Male, Peptide Hormones metabolism, RNA, Messenger genetics, Rats, Rats, Wistar, Receptors, G-Protein-Coupled genetics, Receptors, Ghrelin, Reverse Transcriptase Polymerase Chain Reaction, Seminiferous Tubules metabolism, Signal Transduction physiology, Spermatogenesis physiology, Testis cytology, Gene Expression Regulation, Developmental physiology, Hormones physiology, RNA, Messenger biosynthesis, Receptors, G-Protein-Coupled biosynthesis, Testis growth & development, Testis metabolism
- Abstract
Recent evidence from our research suggested the direct role of ghrelin in the control of testicular function. However, the pattern of expression and hormonal regulation of the gene encoding its cognate receptor (i.e., the growth hormone-secretagogue receptor [GHS-R]) in the male gonad remains to be fully elucidated. In this paper, overall expression of GHS-R mRNA in rat testis was compared with that of the functional receptor form, namely GHS-R type 1a, in different developmental and experimental settings. In addition, cellular distribution of GHS-R within adult testis tissue was assessed. Our analyses demonstrated persistent expression of the GHS-R gene in rat testis throughout postnatal development. In contrast, testicular expression of GHS-R type 1a mRNA remained undetectable before puberty and sharply increased thereafter. In adult testis, GHS-R1a mRNA expression presented a scattered pattern of cellular distribution, including Sertoli and Leydig cells that also showed specific GHS-R1a immunoreactivity. Expression of total GHS-R and specific GHS-R1a mRNAs was detected in isolated seminiferous tubule preparations, with varying levels throughout the defined stages of the spermatogenic cycle. In addition, testicular expression of total GHS-R and GHS-R1a mRNAs was up-regulated by exposure to ghrelin in vitro and after stimulation with FSH in vivo. In conclusion, our data demonstrate that expression of the GHS-R gene in rat testis takes place in a developmental, stage-specific, and hormonally regulated manner. Divergent expression of total GHS-R and type 1a specific mRNAs was detected at certain stages of postnatal development and spermatogenic cycle, thus raising the possibility that, in addition to net changes in GHS-R gene expression, the balance between receptor subtypes may represent a novel mechanism for the tuning of ghrelin sensitivity in rat testis.
- Published
- 2003
- Full Text
- View/download PDF
42. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer.
- Author
-
Jeffery PL, Herington AC, and Chopin LK
- Subjects
- Alternative Splicing, Amino Acid Sequence, Animals, Cell Division, Ghrelin, Growth Hormone metabolism, Humans, Models, Biological, Models, Genetic, Molecular Sequence Data, Peptide Hormones metabolism, Receptors, G-Protein-Coupled metabolism, Receptors, Ghrelin, Hormones metabolism, Neoplasms metabolism, Peptide Hormones physiology, Receptors, G-Protein-Coupled physiology
- Abstract
Ghrelin is a recently identified 28 amino acid peptide capable of stimulating pituitary growth hormone release in humans. The actions of ghrelin are mediated via the naturally occurring ghrelin receptor, also known as the growth hormone secretagogue receptor (GHS-R). Ghrelin and its receptors are now being recognized as components of the growth hormone axis and are therefore potentially involved in tissue growth and development. As is the case for other members of this axis, evidence is rapidly emerging to indicate that ghrelin/GHS-R may play an important autocrine/paracrine role in some cancers. This review highlights the evidence for the expression, regulation and potential functional role of ghrelin and its receptor in hormone-dependent cancers, such as prostate and breast cancer.
- Published
- 2003
- Full Text
- View/download PDF
43. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary.
- Author
-
Gaytan F, Barreiro ML, Chopin LK, Herington AC, Morales C, Pinilla L, Casanueva FF, Aguilar E, Diéguez C, and Tena-Sempere M
- Subjects
- Antibody Specificity, Female, Ghrelin, Humans, Menstrual Cycle physiology, Peptide Hormones immunology, Receptors, Cell Surface immunology, Receptors, Ghrelin, Ovarian Follicle chemistry, Peptide Hormones analysis, Receptors, Cell Surface analysis, Receptors, G-Protein-Coupled
- Abstract
Ghrelin is a novel 28-amino acid peptide identified as the endogenous ligand for the GH secretagogue receptor (GHS-R). Besides its hallmark central neuroendocrine effects in the control of GH secretion and food intake, an unexpected reproductive facet of ghrelin has recently emerged because expression of this molecule and its cognate receptor has been demonstrated in rat testis. However, whether this signaling system is present in human gonads remains to be evaluated. In this study, we have assessed the presence and cellular location of ghrelin and its functional receptor, namely the type 1a GHS-R, in the cyclic human ovary by means of immunohistochemistry using specific polyclonal antibodies. Strong ghrelin immunostaining was demonstrated in ovarian hilus interstitial cells. In contrast, ghrelin signal was not detected in ovarian follicles at any developmental stage, nor was it present in newly formed corpora lutea (CL) at very early development. However, specific ghrelin immunoreactivity was clearly observed in young and mature CL, whereas expression of the peptide disappeared in regressing luteal tissue. Concerning the cognate receptor, ovarian expression of GHS-R1a protein showed a wider pattern of tissue distribution, with detectable specific signal in oocytes as well as somatic follicular cells; luteal cells from young, mature, old, and regressing CL; and interstitial hilus cells. Of particular note, follicular GHS-R1a peptide expression paralleled follicle development with stronger immunostaining in granulosa and theca layers of healthy antral follicles. In conclusion, our results are the first to demonstrate that ghrelin and its functional type 1a receptor are expressed in the cyclic human ovary with distinct patterns of cellular location. The presence of both components (ligand and receptor) of the ghrelin signaling system within the human ovary opens up the possibility of a potential regulatory role of this novel molecule in ovarian function under physiological and pathophysiological conditions.
- Published
- 2003
- Full Text
- View/download PDF
44. Co-expression of GH and GHR isoforms in prostate cancer cell lines.
- Author
-
Chopin LK, Veveris-Lowe TL, Philipps AF, and Herington AC
- Subjects
- Blotting, Northern, Blotting, Southern, Cell Division, Cell Nucleus metabolism, Culture Media, Conditioned pharmacology, DNA Primers pharmacology, DNA, Complementary metabolism, Exons, Humans, Immunohistochemistry, Male, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Tumor Cells, Cultured, Growth Hormone biosynthesis, Growth Hormone chemistry, Prostatic Neoplasms metabolism, Receptors, Somatotropin biosynthesis, Receptors, Somatotropin chemistry
- Abstract
Prostate cancer is a significant cause of morbidity and mortality in Western males. While it is known that androgens play a central role in prostate cancer development and progression, other hormones and growth factors are also involved in prostate growth. Insulin-like growth factor-I (IGF-I) plasma levels have been associated with prostate cancer risk, and growth hormone (GH), a major factor regulating IGF levels, also appears to have a role in prostate cancer cell growth. Most significantly, GH has been shown to increase the rate of cell proliferation in prostate cancer cell lines. We have now demonstrated the co-expression of GH and GH receptor (GHR) mRNA isoforms in the ALVA41, PC3, DU145, LNCaP prostate cancer cells by reverse transcription polymerase chain reaction. Sequence analysis has confirmed that these cell lines express the pituitary form of GH mRNA and also the placental mRNA isoform. These prostate cancer cell lines also express the full-length mRNA for the GHR and the exon 3 deleted isoform. We have also demonstrated the presence of GH and GHR proteins in these cell lines by immunohistochemistry. GH expression has not been described previously in human prostate cancer cells. The co-expression of GH and its receptor would enable an autocrine-paracrine pathway to exist in the prostate that would be capable of stimulating prostate growth, either directly via the GHR or indirectly via IGF production. The GH axis in the prostate could therefore be an important additional target for the future development of prostate cancer therapies.
- Published
- 2002
- Full Text
- View/download PDF
45. Unusual ovarian activity in a mare preceding the development of an ovarian granulosa cell tumour.
- Author
-
Chopin JB, Chopin LK, Knott LM, de Kretser DM, and Dowsett KF
- Subjects
- Animals, Diagnosis, Differential, Female, Granulosa Cell Tumor blood, Granulosa Cell Tumor diagnosis, Hormones blood, Horse Diseases pathology, Horse Diseases surgery, Horses, Ovarian Neoplasms blood, Ovarian Neoplasms diagnosis, Granulosa Cell Tumor veterinary, Horse Diseases diagnosis, Ovarian Neoplasms veterinary, Ovary metabolism
- Abstract
An 8-year-old mare, with a foal at foot, was inseminated on foal heat with frozen semen, with the resultant pregnancy lost between days 34 and 41. The right ovary developed a large anovulatory follicle that was non-responsive to multiple doses of ovulating agents. The follicle eventually appeared to luteinise, although plasma progesterone concentrations did not reflect this. Another follicle developed, responded to GnRH and resulted in a pregnancy from frozen semen that went to term with a healthy foal. When the mare was examined after foaling, the structure on the right ovary appeared to be a granulosa cell tumour; the left ovary was smaller than normal and non-functional. Surgical removal of the right ovary before increasing photoperiod resulted in a return to function of the left ovary and a pregnancy to frozen semen on the second cycle following removal. Figures showing concentrations of inhibin, progesterone, androstenedione, oestradiol and testosterone are presented for this entire period. Unusual ovarian activity in the mare might be a prelude to the development of a granulosa cell tumour.
- Published
- 2002
46. A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines.
- Author
-
Chopin LK and Herington AC
- Subjects
- Blotting, Southern, Cell Division physiology, DNA, Neoplasm biosynthesis, DNA, Neoplasm genetics, Growth Hormone-Releasing Hormone genetics, Humans, Immunohistochemistry, Male, Prostatic Neoplasms genetics, RNA, Messenger biosynthesis, RNA, Messenger genetics, Receptors, Neuropeptide genetics, Receptors, Pituitary Hormone-Regulating Hormone genetics, Reverse Transcriptase Polymerase Chain Reaction, Sequence Analysis, DNA, Tumor Cells, Cultured, Growth Hormone-Releasing Hormone biosynthesis, Prostatic Neoplasms metabolism, Prostatic Neoplasms pathology, Receptors, Neuropeptide biosynthesis, Receptors, Pituitary Hormone-Regulating Hormone biosynthesis
- Abstract
Background: Recent studies have shown that GHRH antagonists inhibit prostate tumour growth and IGF-II production both in vivo and in vitro. The mechanism underlying these observations is unknown, but may involve an interaction with a prostatic GHRH receptor (GHRH-R), raising the possibility of an autocrine pathway for the GHRH axis in the prostate., Methods: GHRH and GHRH-R mRNA expression was examined by RT-PCR in human prostate cancer cell lines, and the authenticity of PCR products was confirmed by Southern analysis and cDNA sequencing. Immunohistochemical techniques were used to examine the expression of GHRH protein in prostate cancer cell lines., Results: GHRH-R (mRNA) and GHRH (mRNA and protein) are co-expressed in the ALVA-41, DU145, LNCaP and PC3 human prostate cancer cell lines., Conclusions: These observations suggest the presence of an intact prostatic GHRH autocrine pathway which may stimulate prostate cell proliferation. This pathway may be disrupted by GHRH antagonists., (Copyright 2001 Wiley-Liss, Inc.)
- Published
- 2001
- Full Text
- View/download PDF
47. Morphology and tyrosine-hydroxylase immunohistochemistry of the systemic secondary vessel system of the blue catfish, Arius graeffei.
- Author
-
Chopin LK and Bennett MB
- Abstract
Fish have a secondary vessel system which emerges from the primary vasculature via large numbers of coiled origins. The precise role of this vessel system is unknown. Vascular casting techniques and scanning electron microscopy reveal that the secondary vessels of the blue catfish, Arius graeffei, originate from dorsal, lateral, and ventral segmental primary arteries and from the caudal dorsal aorta. These vessels anastomose with each other to form larger secondary arteries which parallel the primary vessels for their entire length. Secondary vessels do not appear to form a capillary bed in the skin in A. graeffei as they do in some fish species. Coiled secondary vessel origins are abundant within the tunica media and adventitia of the primary vessels from which they emerge. The origins of the secondary vessels are surrounded by the extensive cytoplasmic processes of specialized endothelial cells. These processes extend for up to 6 μm into the lumen of the primary vessel. Ultrastructurally the coiled secondary capillaries consist of an endothelial cell tube which is surrounded by a single layer of pericytes. These endothelial cells extend large numbers of microvilli into the lumen of the coiled secondary capillary. Nerve terminals are commonly associated with the coiled secondary capillaries. Immunohistochemistry has revealed the presence of tyrosine-hydroxylase, an enzyme involved in catecholamine synthesis in nerve varicosities close to secondary vessels in A. graeffei. This vessel system could therefore be regulated by adrenergic nerves. © 1996 Wiley-Liss, Inc., (Copyright © 1996 Wiley-Liss, Inc.)
- Published
- 1996
- Full Text
- View/download PDF
48. Cellular ultrastructure and catecholamine histofluorescence of the heart of the Australian lungfish, Neoceratodus forsteri.
- Author
-
Chopin LK and Bennett MB
- Abstract
Ultrastructural descriptions of the dipnoan heart are lacking. Many ultrastructural features of the heart of the Australian lungfish, Neoceratodus forsteri, resemble those of other lower vertebrates. The epicardial cells appear to be adapated for the exchange of material with the pericardial fluid. The most prominent features of the endocardial cells are numerous moderately electron-dense vesicles found within the cytoplasm. These organelles might have an endocrine function. The myocardiocytes are typically small. The banding pattern of the sarcomere is shared with most fish. The intercalated disc has a convoluted path and consists of desmosomes and fascia adherens. Caveolae are a prominent feature of the sarcoplasm. The sarcoplasmic reticulum is sparse, and T-tubules are lacking. Atrial myocardial dense bodies occur in vast numbers throughout the atrium and are occasionally seen in the ventricle. These vesicles are chromaffin-positive but fail to show catecholamine fluorescence. They are likely to contain peptides related to ANP. Subendothelial cells exhibiting catecholamine-specific fluorescence are scattered throughout the atrium. Ultrastructurally these cells contain many chromaffin-positive granules. Chromaffin cells represent another cell type with a probable endocrine function within the heart of N. forsteri. © 1995 Wiley-Liss, Inc., (Copyright © 1995 Wiley-Liss, Inc.)
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.